_version_ 1784888000899973120
author Canaday, David H.
Oyebanji, Oladayo A.
White, Elizabeth M.
Bosch, Jürgen
Nugent, Clare
Vishnepolskiy, Igor
Abul, Yasin
Didion, Elise M.
Paxitzis, Alexandra
Sundheimer, Nicholas
Ragavapuram, Vaishnavi
Wilk, Dennis
Keresztesy, Debbie
Cao, Yi
St. Denis, Kerri
McConeghy, Kevin W.
McDonald, L. Clifford
Jernigan, John A.
Mylonakis, Eleftherios
Wilson, Brigid M.
King, Christopher L.
Balazs, Alejandro B.
Gravenstein, Stefan
author_facet Canaday, David H.
Oyebanji, Oladayo A.
White, Elizabeth M.
Bosch, Jürgen
Nugent, Clare
Vishnepolskiy, Igor
Abul, Yasin
Didion, Elise M.
Paxitzis, Alexandra
Sundheimer, Nicholas
Ragavapuram, Vaishnavi
Wilk, Dennis
Keresztesy, Debbie
Cao, Yi
St. Denis, Kerri
McConeghy, Kevin W.
McDonald, L. Clifford
Jernigan, John A.
Mylonakis, Eleftherios
Wilson, Brigid M.
King, Christopher L.
Balazs, Alejandro B.
Gravenstein, Stefan
author_sort Canaday, David H.
collection PubMed
description
format Online
Article
Text
id pubmed-9925133
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-99251332023-02-16 SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022 Canaday, David H. Oyebanji, Oladayo A. White, Elizabeth M. Bosch, Jürgen Nugent, Clare Vishnepolskiy, Igor Abul, Yasin Didion, Elise M. Paxitzis, Alexandra Sundheimer, Nicholas Ragavapuram, Vaishnavi Wilk, Dennis Keresztesy, Debbie Cao, Yi St. Denis, Kerri McConeghy, Kevin W. McDonald, L. Clifford Jernigan, John A. Mylonakis, Eleftherios Wilson, Brigid M. King, Christopher L. Balazs, Alejandro B. Gravenstein, Stefan MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2023-01-27 /pmc/articles/PMC9925133/ /pubmed/36701254 http://dx.doi.org/10.15585/mmwr.mm7204a4 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Canaday, David H.
Oyebanji, Oladayo A.
White, Elizabeth M.
Bosch, Jürgen
Nugent, Clare
Vishnepolskiy, Igor
Abul, Yasin
Didion, Elise M.
Paxitzis, Alexandra
Sundheimer, Nicholas
Ragavapuram, Vaishnavi
Wilk, Dennis
Keresztesy, Debbie
Cao, Yi
St. Denis, Kerri
McConeghy, Kevin W.
McDonald, L. Clifford
Jernigan, John A.
Mylonakis, Eleftherios
Wilson, Brigid M.
King, Christopher L.
Balazs, Alejandro B.
Gravenstein, Stefan
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
title SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
title_full SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
title_fullStr SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
title_full_unstemmed SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
title_short SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
title_sort sars-cov-2 antibody responses to the ancestral sars-cov-2 strain and omicron ba.1 and ba.4/ba.5 variants in nursing home residents after receipt of bivalent covid-19 vaccine — ohio and rhode island, september–november 2022
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925133/
https://www.ncbi.nlm.nih.gov/pubmed/36701254
http://dx.doi.org/10.15585/mmwr.mm7204a4
work_keys_str_mv AT canadaydavidh sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT oyebanjioladayoa sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT whiteelizabethm sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT boschjurgen sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT nugentclare sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT vishnepolskiyigor sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT abulyasin sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT didionelisem sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT paxitzisalexandra sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT sundheimernicholas sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT ragavapuramvaishnavi sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT wilkdennis sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT keresztesydebbie sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT caoyi sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT stdeniskerri sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT mcconeghykevinw sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT mcdonaldlclifford sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT jerniganjohna sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT mylonakiseleftherios sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT wilsonbrigidm sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT kingchristopherl sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT balazsalejandrob sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022
AT gravensteinstefan sarscov2antibodyresponsestotheancestralsarscov2strainandomicronba1andba4ba5variantsinnursinghomeresidentsafterreceiptofbivalentcovid19vaccineohioandrhodeislandseptembernovember2022